Pruthvi Nagilla serves as Senior Director, Bioanalysis and DMPK at Hemab. He has over 15 years of progressive experience as a scientist and as an operational leader in biotech/ biopharma (Asher Bio, Passage Bio, AskBio), bioanalytical CRO (BioAgilytix), and in academic research (Pitt Infectious Diseases). Pruthvi is a cell and molecular biologist by training, with recent experience leading non-clinical and global clinical phase 1/2 bioanalysis for developing immunotherapies (oncology) and gene therapies (rare diseases in neurological, metabolic and cardiovascular therapeutic areas). He earned Master of Science degree in Biotechnology from Georgetown University in Washington, DC.